Form 4: Cimpress CFO Sean Quinn Executes Stock Sale and Option Exercise
Insider Transaction Report
Cimpress CFO Sean Quinn reported the sale of 28,135 shares and the exercise of 5,009 stock options in a recent SEC Form 4 filing.
Summary
- CFO Sean Quinn sold a total of 28,135 ordinary shares across multiple transactions on May 27 and May 28, 2026.
- The sales were executed at weighted-average prices ranging from $103.55 to $105.11 per share.
- Quinn exercised 5,009 stock options at a strike price of $46.20 on May 28, 2026.
- Following these transactions, the reporting person maintains a direct beneficial ownership of 28,937 ordinary shares.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event, as the transactions appear to be standard equity management by an executive rather than a strategic shift.
Positives
- The executive continues to hold a significant position of 28,937 shares, indicating ongoing alignment with shareholder interests.
Negatives
- The filing reflects a net reduction in the executive's direct share ownership following the exercise and subsequent sale of shares.
Risks
- Insider selling activity can sometimes be perceived by the market as a signal of management's view on current valuation.
Future Outlook
No specific forward-looking guidance regarding company operations was provided in this disclosure.
Industry Context
StockSavvy.ai notes that routine insider selling by C-suite executives is common for liquidity or tax planning purposes and does not necessarily reflect a change in the company's fundamental outlook.
Comparison to Industry Standards
- The transaction follows standard executive compensation and equity management practices observed in mid-to-large cap public companies.
Stakeholder Impact
- Minimal impact expected on shareholders as the transactions represent a small portion of total outstanding shares.
Next Steps
- Continued monitoring of future Form 4 filings for further changes in insider holdings.
Key Dates
| Date | Description |
|---|---|
| 2023-06-30 | Initial vesting date for the exercised stock options. |
| 2026-05-27 | Date of initial share sales. |
| 2026-05-28 | Date of option exercise and final share sale. |
| 2026-05-29 | Date of filing signature. |
| 2032-08-15 | Expiration date for the exercised stock options. |
Keywords
Cimpress, CMPR, Insider Trading, Form 4, CFO, Stock Options
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.